BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33556883)

  • 41. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
    Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.
    Zhu Y; Peng Q; Lin Y; Zou L; Shen P; Chen F; Min M; Shen L; Chen J; Shen B
    Oncotarget; 2017 Jan; 8(2):2233-2248. PubMed ID: 27903980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
    Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
    Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.
    Roman-Canal B; Tarragona J; Moiola CP; Gatius S; Bonnin S; Ruiz-Miró M; Sierra JE; Rufas M; González E; Porcel JM; Gil-Moreno A; Falcón-Pérez JM; Ponomarenko J; Matias-Guiu X; Colas E
    J Transl Med; 2019 Jun; 17(1):208. PubMed ID: 31221189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
    Clancy C; Joyce MR; Kerin MJ
    Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA expression profiling provides novel insights into immune-related pathways involved in gastric cancer.
    Martins MR; Almeida RS; Lucena-Silva N; Coutinho-Camilo CM; Torjal I; Dos Santos RL; Miranda-Furtado CL; Rios ÁFL; Torres LC; Begnami MDFS
    Med Oncol; 2019 Aug; 36(9):81. PubMed ID: 31399867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genome-wide microRNA Expression Profiling in Primary Tumors and Matched Liver Metastasis of Patients with Colorectal Cancer.
    Vychytilova-Faltejskova P; Pesta M; Radova L; Liska V; Daum O; Kala Z; Svoboda M; Kiss I; Slaby O
    Cancer Genomics Proteomics; 2016; 13(4):311-6. PubMed ID: 27365381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
    Arndt GM; Dossey L; Cullen LM; Lai A; Druker R; Eisbacher M; Zhang C; Tran N; Fan H; Retzlaff K; Bittner A; Raponi M
    BMC Cancer; 2009 Oct; 9():374. PubMed ID: 19843336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
    Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
    Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
    Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.
    Kjersem JB; Ikdahl T; Lingjaerde OC; Guren T; Tveit KM; Kure EH
    Mol Oncol; 2014 Feb; 8(1):59-67. PubMed ID: 24119443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.
    Manceau G; Imbeaud S; Thiébaut R; Liébaert F; Fontaine K; Rousseau F; Génin B; Le Corre D; Didelot A; Vincent M; Bachet JB; Chibaudel B; Bouché O; Landi B; Bibeau F; Leroy K; Penault-Llorca F; Van Laethem JL; Demetter P; Tejpar S; Rossi S; Mosakhani N; Osterlund P; Ristamäki R; Sarhadi V; Knuutila S; Boige V; André T; Laurent-Puig P
    Clin Cancer Res; 2014 Jun; 20(12):3338-47. PubMed ID: 24771647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression.
    Fonseca A; Ramalhete SV; Mestre A; Pires das Neves R; Marreiros A; Castelo-Branco P; Roberto VP
    Aging (Albany NY); 2021 Sep; 13(18):21991-22029. PubMed ID: 34547721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of microRNAs in colorectal liver metastasis: Important participants and potential clinical significances.
    Wang D; Liu J; Huo T; Tian Y; Zhao L
    Tumour Biol; 2017 Jun; 39(6):1010428317709640. PubMed ID: 28651498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of miR-18a-5p, miR-144-3p, and miR-663b in colorectal cancer and their association with cholesterol homeostasis.
    Sharma B; Randhawa V; Vaiphei K; Gupta V; Dahiya D; Agnihotri N
    J Steroid Biochem Mol Biol; 2021 Apr; 208():105822. PubMed ID: 33465419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.